Page last updated: 2024-10-24

celecoxib and Intestinal Obstruction

celecoxib has been researched along with Intestinal Obstruction in 5 studies

Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shafiq, N1
Malhotra, S1
Pandhi, P1
Mir, O1
Dhote, R1
Scavennec, R1
Ropert, S1
Christoforov, B1
Greene, AK1
Alwayn, IP1
Nose, V1
Flynn, E1
Sampson, D1
Zurakowski, D1
Folkman, J1
Puder, M1
Calvo, N1
Iversen, E1
Munck, LK1
Cahill, RA1

Other Studies

5 other studies available for celecoxib and Intestinal Obstruction

ArticleYear
Effect of cyclooxygenase inhibitors in postoperative ileus: an experimental study.
    Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:5

    Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Indomethaci

2002
Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report.
    Gut, 2004, Volume: 53, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; C

2004
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.
    Annals of surgery, 2005, Volume: 242, Issue:1

    Topics: Animals; Biopsy, Needle; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, Animal; Immunohistoch

2005
[Intestinal side effects of COX-2 inhibitors].
    Ugeskrift for laeger, 2006, Mar-27, Volume: 168, Issue:13

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colonic Diseases; Colonic Pouches;

2006
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.
    Annals of surgery, 2006, Volume: 244, Issue:2

    Topics: Abdomen; Angiogenesis Inhibitors; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, A

2006